cadambine

isolated from Anthocephalus cadamba; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Chandel, Madhu: 1 article (01/2017)
2.	Kaur, Satwinderjeet: 1 article (01/2017)
3.	Kumar, Manish: 1 article (01/2017)
4.	Sharma, Upendra: 1 article (01/2017)
5.	Singh, Bikram: 1 article (01/2017)
6.	Kumar, Deepak: 1 article (08/2015)
7.	Mallick, Sumana: 1 article (08/2015)
8.	Pala, Bikas C: 1 article (08/2015)
9.	Rasamalla, Saiprasanna: 1 article (08/2015)
10.	Tejaswi, Chilukuri: 1 article (08/2015)

1.	Neoplasms (Cancer) 01/01/2017 - "NACB was found to inhibit the growth of colon (COLO 205) cancer cells with GI50 of 54.36 µg/ml. To identify bioactive principles in the active fractions, NACB and EACB were subjected to UPLC-electrospray-ionization-quadrupole time-of-flight mass spectrometry which revealed the presence of 3β-isodihyrocadambine-oxide, cadambine, phelasin A/B, 3β- dihydrocadambine and 3'-O-caffeoylsweroside like compounds. "
2.	Hepatocellular Carcinoma (Hepatoma) 08/01/2015 - "Guided by bio-assay tests using human colorectal (HCT116) and hepatocellular carcinoma (HepG2) cell lines, it has been shown to contain three active constituents, the triterpenoid saponins 3-O-[α-L-rhamnopyranosyl]-quinovic acid (1) and 3-O-[α-L-rhamnopyranosyl]-quinovic acid 28-O-[β-D-glucopyranosyl] ester (2), and the alkaloid cadambine (3). "